From: Serum zinc levels and in vivo beta-amyloid deposition in the human brain
B (95% CI)a | P | |
---|---|---|
Low zinc | 0.056 (− 0.176 to 0.288) | 0.636 |
Medium zinc | 0.119 (−0.061 to 0.299) | 0.193 |
Age | 0.006 (0.003 to 0.009) | < 0.001 |
Low zinc × age | < 0.001 (−0.003 to 0.004) | 0.913 |
Medium zinc × age | −0.001 (− 0.004 to 0.001) | 0.250 |
Low zinc | 0.047 (−0.020 to 0.114) | 0.170 |
Medium zinc | 0.029 (−0.035 to 0.093) | 0.374 |
Sex | 0.002 (− 0.063 to 0.067) | 0.953 |
Low zinc × sex | 0.055 (− 0.038 to 0.149) | 0.247 |
Medium zinc × sex | −0.021 (− 0.111 to 0.068) | 0.637 |
Low zinc | 0.040 (−0.015 to 0.096) | 0.152 |
Medium zinc | 0.016 (− 0.036 to 0.067) | 0.553 |
APOE4 positivity | −0.002 (− 0.086 to 0.082) | 0.958 |
Low zinc × APOE4 positivity | 0.162 (0.040 to 0.284) | 0.010 |
Medium zinc × APOE4 positivity | 0.030 (−0.089 to 0.148) | 0.624 |
Low zinc | 0.101 (0.029 to 0.174) | 0.006 |
Medium zinc | 0.051 (−0.015 to 0.117) | 0.130 |
VRS | 0.008 (−0.023 to 0.040) | 0.607 |
Low zinc × VRS | −0.029 (− 0.080 to 0.022) | 0.260 |
Medium zinc × VRS | −0.028 (− 0.071 to 0.015) | 0.197 |
Low zinc | 0.060 (−0.128 to 0.249) | 0.530 |
Medium zinc | 0.049 (−0.111 to 0.209) | 0.547 |
Copper | < 0.001 (−0.002 to 0.002) | 0.912 |
Low zinc × copper | < 0.001 (−0.002 to 0.002) | 0.904 |
Medium zinc × copper | < 0.001 (−0.002 to 0.001) | 0.699 |
Low zinc | 0.049 (−0.222 to 0.320) | 0.719 |
Medium zinc | 0.112 (−0.101 to 0.324) | 0.300 |
Calcium | 0.050 (−0.022 to 0.122) | 0.175 |
Low zinc × calcium | 0.002 (−0.027 to 0.031) | 0.877 |
Medium zinc × calcium | −0.010 (− 0.033 to 0.012) | 0.365 |
Low zinc | 0.019 (−0.120 to 0.158) | 0.788 |
Medium zinc | 0.059 (−0.066 to 0.184) | 0.351 |
Iron | < 0.001 (< 0.001 to 0.001) | 0.445 |
Low zinc × iron | < 0.001 (−0.001 to 0.002) | 0.390 |
Medium zinc × iron | < 0.001 (−0.001 to 0.001) | 0.451 |